These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 30685678)

  • 1. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
    Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
    Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States.
    Boettiger DC; Newall AT; Phillips A; Bendavid E; Law MG; Ryom L; Reiss P; Mocroft A; Bonnet F; Weber R; El-Sadr W; d'Arminio Monforte A; de Wit S; Pradier C; Hatleberg CI; Lundgren J; Sabin C; Kahn JG; Kazi DS
    J Int AIDS Soc; 2021 Mar; 24(3):e25690. PubMed ID: 33749164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Statin Prescribing Practices and Predictors of Statin Underutilization in Persons With HIV.
    Cottino MC; Kulig CE; Suh JS; Jimenez HR
    J Acquir Immune Defic Syndr; 2023 Apr; 92(4):334-339. PubMed ID: 36729682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy.
    Boccara F; Miantezila Basilua J; Mary-Krause M; Lang S; Teiger E; Steg PG; Funck-Brentano C; Girard PM; Costagliola D; Cohen A; Guiguet M;
    Am Heart J; 2017 Jan; 183():91-101. PubMed ID: 27979047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.
    Eastwood SV; Mathur R; Sattar N; Smeeth L; Bhaskaran K; Chaturvedi N
    PLoS Med; 2021 Jun; 18(6):e1003672. PubMed ID: 34185782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease.
    Mochari-Greenberger H; Liao M; Mosca L
    Am J Cardiol; 2014 Feb; 113(3):413-7. PubMed ID: 24295550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients.
    Blackman AL; Pandit NS; Pincus KJ
    HIV Med; 2020 Mar; 21(3):135-141. PubMed ID: 31876122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.
    Hsieh HC; Hsu JC; Lu CY
    BMJ Open; 2017 May; 7(5):e014150. PubMed ID: 28515189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease.
    Gallegos Aragon K; Ray G; Conklin J; Stever E; Marquez C; Magallanes A; Anderson J; Jakeman B
    Am J Health Syst Pharm; 2022 Nov; 79(22):2026-2031. PubMed ID: 35976174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis.
    Boettiger DC; Newall AT; Chattranukulchai P; Chaiwarith R; Khusuwan S; Avihingsanon A; Phillips A; Bendavid E; Law MG; Kahn JG; Ross J; Bautista-Arredondo S; Kiertiburanakul S
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25494. PubMed ID: 32562359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection.
    Mehraj V; Chen J; Routy JP
    Front Immunol; 2024; 15():1339338. PubMed ID: 38655259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is race or ethnicity associated with under-utilization of statins among women in the United States: The study of women's health across the nation.
    Jackson EA; Ruppert K; Derby CA; Lian Y; Chae CU; Kazlauskaite R; Neal-Perry G; El Khoudary SR; Harlow SD; Solomon DH
    Clin Cardiol; 2020 Dec; 43(12):1388-1397. PubMed ID: 32862481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study.
    Larson D; Won SH; Ganesan A; Maves RC; Kronmann K; Okulicz JF; Chu X; Schofield C; O'Bryan T; Agan BK; Deiss R
    HIV Med; 2022 Mar; 23(3):249-258. PubMed ID: 34704330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.
    Gebhardt A; Fichtenbaum CJ
    Expert Opin Pharmacother; 2019 Oct; 20(14):1719-1729. PubMed ID: 31232617
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field.
    Avgousti H; Feinstein MJ
    Top Antivir Med; 2023 Dec; 31(5):559-565. PubMed ID: 38198667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.